Impairments in intracellular transport are the hallmark of many neurological diseases including hereditary spastic paraplegia (HSP). HSP is a genetically heterogeneous neurodegenerative disorder causing spastic weakness of the lower extremities. On the cellular level the disease is characterized by distal axonopathy that affects the longest axons in the corticospinal tract. At present at least 45 HSP loci have been described. Mutations in atlastin and spastin (accounting for around 50% of all HSP cases) as well as mutations in 6 other identified SPG genes: (kif5a, nipa, spatacsin, spastizin, spartin and maspardin) have been implicated in disturbance of axonal transport and membrane trafficking. The fact that spinal neurons with the longest ...